PP
CYTK icon

Paloma Partners’s Cytokinetics CYTK Stock Holding History

Paloma Partners’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,394
Closed -$1.64M – 1285
2024
Q1 		$1.64M Buy
+23,394
New +$1.81M 0.09% 259
2016
Q2 		– Sell
-16,460
Closed -$116K – 2174
2016
Q1 		$116K Buy
+16,460
New +$120K ﹤0.01% 1753
2015
Q1 		– Sell
-10,900
Closed -$87K – 1238
2014
Q4 		$87K Buy
+10,900
New +$46.8K ﹤0.01% 1078

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Paloma Partners's CYTK Position: Q2 2024 in Review

Paloma Partners sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 23,394 shares — an estimated $1.64M sold.

Paloma Partners first reported a position in CYTK in Q4 2014 and held it in 3 quarters. The position peaked at $1.64M in Q1 2024. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • Paloma Partners reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • Paloma Partners sold 23,394 Cytokinetics shares in Q2 2024, an estimated $1.64M.
  • Paloma Partners first reported a position in Cytokinetics in Q4 2014 and held it in 3 quarters.
  • Paloma Partners's Cytokinetics position peaked at $1.64M in Q1 2024.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on Paloma Partners's 13F filing for Q2 2024, filed 14 Aug 2024.